Radiofrequency ablation for hepatocellular carcinoma and liver metastases: experience in Hospital La Paz.
BACKGROUND
Radiofrequency ablation for patients presenting with non-resectable primary or metastatic liver tumours seems to be a valid therapeutic alternative. In the present study, we show a descriptive list of indications, results and complications of Radiofrequency Ablation Technique for treating non-resectable solid hepatic tumours.


METHODS
Twenty two patients were included in this study; eleven of them (50%) sustained liver metastases from colorectal adenocarcinoma, ten patients (45.5%) had hepatocellular carcinoma and 1 patient had insulinoma.


RESULTS
Local recurrence rate of hepatocellular carcinoma was 22.7% and 27.3% for colorectal carcinoma, after a respective median follow-up of 21 and 14 months. Complications rate was 6.9% and technique-associated mortality rate was 0%.


CONCLUSIONS
Radiofrequency ablation is an easy to make, safe and useful technique for the treatment of primary and metastatic liver tumours.
Gómez Senent
Silvia
S
Department of Gastroenterology, La Paz University Hospital, Madrid, Spain. silviagsenent@yahoo.es
Gómez Raposo
César
C
Manceñido Marcos
Noemi
N
Martín Chavarri
Sonia
S
Carrión Alonso
Gemma
G
Olveira Martín
Antonio
A
Segura Cabral
José María
JM
González Barón
Manuel
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D017115:Catheter Ablation; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013030:Spain; D016896:Treatment Outcome